Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$79.22 - $105.37 $61,078 - $81,240
-771 Reduced 7.99%
8,875 $904,000
Q1 2023

May 09, 2023

BUY
$30.85 - $93.17 $276,014 - $833,591
8,947 Added 1279.97%
9,646 $877,000
Q4 2022

Feb 13, 2023

BUY
$22.15 - $42.11 $3,366 - $6,400
152 Added 27.79%
699 $26,000
Q3 2022

Oct 27, 2022

SELL
$19.41 - $36.49 $15,372 - $28,900
-792 Reduced 59.15%
547 $14,000
Q2 2022

Aug 01, 2022

SELL
$20.71 - $36.5 $10,044 - $17,702
-485 Reduced 26.59%
1,339 $41,000
Q1 2022

May 11, 2022

BUY
$24.12 - $39.6 $39,725 - $65,221
1,647 Added 930.51%
1,824 $60,000
Q4 2021

Feb 11, 2022

BUY
$25.61 - $110.96 $2,125 - $9,209
83 Added 88.3%
177 $5,000
Q3 2021

Nov 10, 2021

SELL
$100.0 - $143.02 $53,300 - $76,229
-533 Reduced 85.01%
94 $9,000
Q2 2021

Aug 05, 2021

SELL
$78.27 - $151.29 $14,166 - $27,383
-181 Reduced 22.4%
627 $89,000
Q1 2021

Apr 28, 2021

SELL
$94.25 - $132.81 $20,735 - $29,218
-220 Reduced 21.4%
808 $81,000
Q4 2020

Feb 04, 2021

BUY
$102.03 - $184.62 $30,609 - $55,386
300 Added 41.21%
1,028 $127,000
Q3 2020

Nov 10, 2020

BUY
$93.53 - $163.34 $4,582 - $8,003
49 Added 7.22%
728 $71,000
Q2 2020

Aug 07, 2020

SELL
$126.3 - $176.56 $3,283 - $4,590
-26 Reduced 3.69%
679 $105,000
Q1 2020

May 13, 2020

BUY
$124.16 - $247.74 $57,113 - $113,960
460 Added 187.76%
705 $101,000
Q4 2019

Feb 04, 2020

BUY
$74.57 - $217.92 $17,151 - $50,121
230 Added 1533.33%
245 $50,000
Q3 2019

Nov 08, 2019

BUY
$71.26 - $95.75 $1,068 - $1,436
15 New
15 $1,000

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.